Literature DB >> 18171679

Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of Slingshot or LIM kinase.

Yuji Horita1, Kazumasa Ohashi, Mutsuko Mukai, Masahiro Inoue, Kensaku Mizuno.   

Abstract

Actin cytoskeletal reorganization is essential for tumor cell migration, adhesion, and invasion. Cofilin and actin-depolymerizing factor (ADF) act as key regulators of actin cytoskeletal dynamics by stimulating depolymerization and severing of actin filaments. Cofilin/ADF are inactivated by phosphorylation of Ser-3 by LIM kinase-1 (LIMK1) and reactivated by dephosphorylation by Slingshot-1 (SSH1) and -2 (SSH2) protein phosphatases. In this study, we examined the roles of cofilin/ADF, LIMK1, and SSH1/SSH2 in tumor cell invasion, using an in vitro transcellular migration assay. In this assay, rat ascites hepatoma (MM1) cells were overlaid on a primary-cultured rat mesothelial cell monolayer and the number of cell foci that transmigrated underneath the monolayer in the presence of lysophosphatidic acid (LPA) was counted. The knockdown of cofilin/ADF, LIMK1, or SSH1/SSH2 expression by small interfering RNAs (siRNAs) significantly decreased the LPA-induced transcellular migration of MM1 cells and their motility in two-dimensional culture. Knockdown of LIMK1 also suppressed fibronectin-mediated cell attachment and focal adhesion formation. Our results suggest that both LIMK1-mediated phosphorylation and SSH1/SSH2-mediated dephosphorylation of cofilin/ADF are critical for the migration and invasion of tumor cells and that LIMK1 is involved in the transcellular migration of tumor cells by enhancing both adhesion and motility of the cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18171679     DOI: 10.1074/jbc.M706538200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Silence of ezrin modifies migration and actin cytoskeleton rearrangements and enhances chemosensitivity of lung cancer cells in vitro.

Authors:  Qing-Yong Chen; Wei Xu; De-Min Jiao; Li-Jun Wu; Jia Song; Jie Yan; Jian-Guo Shi
Journal:  Mol Cell Biochem       Date:  2013-02-22       Impact factor: 3.396

2.  Molecular pathways: targeting the kinase effectors of RHO-family GTPases.

Authors:  Tatiana Y Prudnikova; Sonali J Rawat; Jonathan Chernoff
Journal:  Clin Cancer Res       Date:  2014-10-21       Impact factor: 12.531

3.  LIM kinase 1 acts as a profibrotic mediator in permanent atrial fibrillation patients with valvular heart disease.

Authors:  Qinhua Chen; Ryan C Gimple; Guannan Li; Jianzhou Chen; Han Wu; Ran Li; Jun Xie; Biao Xu
Journal:  J Biosci       Date:  2019-03       Impact factor: 1.826

4.  Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitors.

Authors:  Yan Yin; Ke Zheng; Nibal Eid; Shannon Howard; Ji-Hak Jeong; Fei Yi; Jia Guo; Chul Min Park; Mathieu Bibian; Weilin Wu; Pamela Hernandez; HaJeung Park; Yuntao Wu; Jun-Li Luo; Philip V LoGrasso; Yangbo Feng
Journal:  J Med Chem       Date:  2015-02-04       Impact factor: 7.446

5.  Slingshot isoform-specific regulation of cofilin-mediated vascular smooth muscle cell migration and neointima formation.

Authors:  Rebecca A Torres; Douglas A Drake; Viktoriya Solodushko; Rashmi Jadhav; Erika Smith; Petra Rocic; David S Weber
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

6.  LIM kinase inhibition reduces breast cancer growth and invasiveness but systemic inhibition does not reduce metastasis in mice.

Authors:  Rong Li; Judy Doherty; Juliana Antonipillai; Sheng Chen; Mark Devlin; Kathryn Visser; Jonathan Baell; Ian Street; Robin L Anderson; Ora Bernard
Journal:  Clin Exp Metastasis       Date:  2012-12-13       Impact factor: 5.150

7.  Allosteric modulation of the catalytic VYD loop in Slingshot by its N-terminal domain underlies both Slingshot auto-inhibition and activation.

Authors:  Duxiao Yang; Peng Xiao; Qing Li; Xiaolei Fu; Chang Pan; Di Lu; Shishuai Wen; Wanying Xia; Dongfang He; Hui Li; Hao Fang; Yuemao Shen; Zhigang Xu; Amy Lin; Chuan Wang; Xiao Yu; Jiawei Wu; Jinpeng Sun
Journal:  J Biol Chem       Date:  2018-08-28       Impact factor: 5.157

8.  LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance.

Authors:  Helen Aggelou; Panagiota Chadla; Sofia Nikou; Sofia Karteri; Ioannis Maroulis; Haralabos P Kalofonos; Helen Papadaki; Vasiliki Bravou
Journal:  Virchows Arch       Date:  2018-01-19       Impact factor: 4.064

Review 9.  The impact of phosphatases on proliferative and survival signaling in cancer.

Authors:  Goutham Narla; Jaya Sangodkar; Christopher B Ryder
Journal:  Cell Mol Life Sci       Date:  2018-05-03       Impact factor: 9.261

10.  Ca2+/calmodulin-dependent protein kinase IV-mediated LIM kinase activation is critical for calcium signal-induced neurite outgrowth.

Authors:  Miyohiko Takemura; Toshiaki Mishima; Yan Wang; Jiro Kasahara; Kohji Fukunaga; Kazumasa Ohashi; Kensaku Mizuno
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.